# Clinical Trial Landscape: 09_prostate_brca2

*Generated: 2026-01-05 06:59:11*

## Summary

- **Total Trials**: 100
- **Flagged for Review**: 0
- **Search Terms Used**: 11

## Phase Distribution

| Phase | Count | Distribution |
|-------|-------|--------------|
| Phase 2 | 22 | ████ 22.0% |
| Phase 1 | 21 | ████ 21.0% |
| Unknown | 19 | ███ 19.0% |
| Phase 1/Phase 2 | 15 | ███ 15.0% |
| Phase 3 | 11 | ██ 11.0% |
| Not Applicable | 9 | █ 9.0% |
| Phase 4 | 2 |  2.0% |
| Early Phase 1 | 1 |  1.0% |

## Status Distribution

- **Recruiting**: 95 (95.0%)
- **Not yet recruiting**: 4 (4.0%)
- **Enrolling by invitation**: 1 (1.0%)

## Top Sponsors

| Sponsor | Trial Count |
|---------|-------------|
| National Cancer Institute (NCI) | 6 |
| SWOG Cancer Research Network | 4 |
| M.D. Anderson Cancer Center | 3 |
| Fred Hutchinson Cancer Center | 3 |
| University of Kansas Medical Center | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Weill Medical College of Cornell University | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Regeneron Pharmaceuticals | 2 |
| VA Office of Research and Development | 2 |
| Amgen | 2 |
| Janssen Research & Development, LLC | 2 |
| University of Utah | 2 |
| University of Chicago | 2 |

## Interventions

| Intervention | Occurrences |
|--------------|-------------|
| Enzalutamide | 14 |
| Biospecimen Collection | 13 |
| Computed Tomography | 11 |
| Magnetic Resonance Imaging | 8 |
| Carboplatin | 6 |
| Bone Scan | 6 |
| Olaparib | 5 |
| Questionnaire Administration | 5 |
| Abiraterone | 5 |
| Docetaxel | 5 |
| Positron Emission Tomography | 5 |
| Pembrolizumab | 4 |
| REGN5678 | 3 |
| Cemiplimab | 3 |
| Apalutamide | 3 |
| Abiraterone acetate | 3 |
| Prednisone | 3 |
| Darolutamide | 3 |
| Cyclophosphamide | 3 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 3 |

## Geographic Distribution

| Country | Trial Count |
|---------|-------------|
| United States | 100 |
| Spain | 15 |
| Australia | 14 |
| Canada | 13 |
| France | 11 |
| China | 11 |
| Italy | 10 |
| United Kingdom | 10 |
| Germany | 9 |
| Netherlands | 8 |
| Poland | 8 |
| Turkey (Türkiye) | 8 |
| South Korea | 8 |
| Taiwan | 8 |
| Brazil | 7 |

## Search Term Provenance

| Term | Source | Confidence |
|------|--------|------------|
| BRCA2 germline mutation | manual | 1.0 |
| prostate cancer | manual | 1.0 |
| BRCA2 germline mutation prostate cancer | manual | 1.0 |
| BRCA2 germline mutation mCRPC | llm | 0.9 |
| germline BRCA2 mutation prostate cancer | llm | 0.9 |
| mCRPC | llm | 0.8 |
| metastatic castration-resistant prostate cancer | llm | 0.8 |
| BRCA2 mutation | llm | 0.9 |
| BRCA2mutation | llm | 0.8 |
| BRCA2-mutation | llm | 0.8 |
| germline BRCA2 mutation | llm | 0.9 |

## All Trials

| NCT ID | Phase | Status | Sponsor | Title |
|--------|-------|--------|---------|-------|
| [NCT06824818](https://clinicaltrials.gov/study/NCT06824818) | Not Applicable | Recruiting | University of Chicag... | A Feasibility Trial of LHRH Agonist... |
| [NCT06906471](https://clinicaltrials.gov/study/NCT06906471) | Phase 1/Phase 2 | Not yet recruiting | Antelope Surgical So... | A Single-Arm, Blinded, Fluorescent ... |
| [NCT06138067](https://clinicaltrials.gov/study/NCT06138067) | Not Applicable | Recruiting | Sidney Kimmel Compre... | A Pilot Study of Low Versus High In... |
| [NCT06674863](https://clinicaltrials.gov/study/NCT06674863) | Not Applicable | Recruiting | Emory University | Addressing Health Literacy With a T... |
| [NCT06826768](https://clinicaltrials.gov/study/NCT06826768) | Phase 1 | Recruiting | M.D. Anderson Cancer... | A Phase Ib Clinical Trial to Optimi... |
| [NCT06555588](https://clinicaltrials.gov/study/NCT06555588) | Not Applicable | Recruiting | Duke University | Engage: A Randomized Controlled Tri... |
| [NCT05873192](https://clinicaltrials.gov/study/NCT05873192) | Phase 2 | Recruiting | M.D. Anderson Cancer... | Presurgical Phase II Study of Talaz... |
| [NCT06533644](https://clinicaltrials.gov/study/NCT06533644) | Phase 2 | Recruiting | Syncromune, Inc. | A Phase 2a Multicenter, Dose-Escala... |
| [NCT06574880](https://clinicaltrials.gov/study/NCT06574880) | Phase 1/Phase 2 | Recruiting | Angela Y. Jia, MD Ph... | STARLiT: STereotActic Body Radiothe... |
| [NCT06801236](https://clinicaltrials.gov/study/NCT06801236) | Phase 1 | Recruiting | Acerand Therapeutics... | A Phase 1 Study to Assess the Safet... |
| [NCT06907043](https://clinicaltrials.gov/study/NCT06907043) | Phase 1/Phase 2 | Recruiting | Eikon Therapeutics | A Phase 1/2, Open-label, Multicente... |
| [NCT06764485](https://clinicaltrials.gov/study/NCT06764485) | Phase 3 | Recruiting | Celgene | A Phase 3, Two-part, Randomized, Op... |
| [NCT06800313](https://clinicaltrials.gov/study/NCT06800313) | Phase 1/Phase 2 | Recruiting | Halda Therapeutics O... | Phase 1/2 Study of HLD-0915 in Pati... |
| [NCT06785636](https://clinicaltrials.gov/study/NCT06785636) | Phase 1/Phase 2 | Recruiting | Pathos AI, Inc. | A Phase 1b/2a, MultiCenter, Open- L... |
| [NCT06632977](https://clinicaltrials.gov/study/NCT06632977) | Phase 2 | Recruiting | Alliance for Clinica... | PREcision DIagnostics in Prostate C... |
| [NCT06609005](https://clinicaltrials.gov/study/NCT06609005) | Phase 1/Phase 2 | Recruiting | Shenzhen Ionova Life... | A Phase 1 and Phase 2, Multi-Center... |
| [NCT06710379](https://clinicaltrials.gov/study/NCT06710379) | Phase 1 | Recruiting | Adcentrx Therapeutic... | A Phase 1a/b Study of ADRX-0405 in ... |
| [NCT06305598](https://clinicaltrials.gov/study/NCT06305598) | Phase 1 | Recruiting | Roswell Park Cancer ... | Bipolar Androgen Therapy in Metasta... |
| [NCT04662580](https://clinicaltrials.gov/study/NCT04662580) | Phase 1 | Recruiting | Janssen Research & D... | A Phase 1, Multicenter, Open-Label,... |
| [NCT06568562](https://clinicaltrials.gov/study/NCT06568562) | Phase 2 | Recruiting | University of Utah | PRO-XL: A Phase II Study of XL092 i... |
| [NCT06691984](https://clinicaltrials.gov/study/NCT06691984) | Phase 3 | Recruiting | Amgen | A Phase 3, Open-label, Multicenter,... |
| [NCT06470243](https://clinicaltrials.gov/study/NCT06470243) | Phase 3 | Recruiting | SWOG Cancer Research... | A Phase III Study of Cabazitaxel Wi... |
| [NCT06236139](https://clinicaltrials.gov/study/NCT06236139) | Phase 1/Phase 2 | Recruiting | Fred Hutchinson Canc... | Phase 1/2 Dose-Escalation and Cohor... |
| [NCT06193486](https://clinicaltrials.gov/study/NCT06193486) | Phase 1 | Recruiting | H. Lee Moffitt Cance... | A Phase I Clinical Trial of an Infu... |
| [NCT06629779](https://clinicaltrials.gov/study/NCT06629779) | Phase 3 | Recruiting | Pfizer | A PHASE 3, RANDOMIZED, DOUBLE BLIND... |
| [NCT06551324](https://clinicaltrials.gov/study/NCT06551324) | Phase 3 | Recruiting | Pfizer | A PHASE 3, RANDOMIZED, OPEN-LABEL S... |
| [NCT06545955](https://clinicaltrials.gov/study/NCT06545955) | Phase 3 | Recruiting | Ferring Pharmaceutic... | A Phase 3, Randomised, Multi-center... |
| [NCT06145633](https://clinicaltrials.gov/study/NCT06145633) | Phase 2 | Recruiting | Fred Hutchinson Canc... | Vorinostat to Augment Response to 1... |
| [NCT05411354](https://clinicaltrials.gov/study/NCT05411354) | N/A | Not yet recruiting | Power Life Sciences ... | Analyzing Clinical Trial Experience... |
| [NCT06492122](https://clinicaltrials.gov/study/NCT06492122) | Phase 1 | Recruiting | Full-Life Technologi... | A Phase 1, First-in-Human, Open-lab... |
| [NCT06582017](https://clinicaltrials.gov/study/NCT06582017) | Phase 1 | Recruiting | Nammi Therapeutics I... | A First-in-human Phase 1a/1b Study ... |
| [NCT06288113](https://clinicaltrials.gov/study/NCT06288113) | Phase 2 | Recruiting | Jonsson Comprehensiv... | Re-Treatment With 177Lu-PSMA-617 Mo... |
| [NCT06520345](https://clinicaltrials.gov/study/NCT06520345) | Phase 3 | Recruiting | Telix Pharmaceutical... | A Multinational, Multicenter, Prosp... |
| [NCT05919329](https://clinicaltrials.gov/study/NCT05919329) | Phase 4 | Recruiting | OHSU Knight Cancer I... | Modulation of PSMA Expression in Ca... |
| [NCT06457919](https://clinicaltrials.gov/study/NCT06457919) | Phase 1/Phase 2 | Recruiting | Memorial Sloan Kette... | A Phase 1b/2 Study Evaluating the A... |
| [NCT06378866](https://clinicaltrials.gov/study/NCT06378866) | Phase 2 | Recruiting | Mayo Clinic | MC230502 Dynamic Investigator Initi... |
| [NCT06398639](https://clinicaltrials.gov/study/NCT06398639) | Not Applicable | Recruiting | Adam S. Kibel, MD | Polygenic Risk Stratification Combi... |
| [NCT06004661](https://clinicaltrials.gov/study/NCT06004661) | Phase 2 | Recruiting | Novartis Pharmaceuti... | An Open-label Dosimetry, Biodistrib... |
| [NCT06257264](https://clinicaltrials.gov/study/NCT06257264) | Phase 1 | Recruiting | BeiGene | A Phase 1a/1b Study of BG-68501, a ... |
| [NCT06242470](https://clinicaltrials.gov/study/NCT06242470) | Phase 1 | Recruiting | MacroGenics | A Phase 1/1b First-in-Human, Open L... |
| [NCT05806515](https://clinicaltrials.gov/study/NCT05806515) | Phase 2 | Recruiting | SWOG Cancer Research... | S2210 A Phase II Study of Neoadjuva... |
| [NCT06177171](https://clinicaltrials.gov/study/NCT06177171) | Phase 1 | Recruiting | Pamela Munster | A Phase I/Ib Study of Olaparib and ... |
| [NCT06062745](https://clinicaltrials.gov/study/NCT06062745) | Phase 1 | Recruiting | Brigham and Women's ... | A Pilot Study for Detection of PSMA... |
| [NCT05849298](https://clinicaltrials.gov/study/NCT05849298) | Phase 2 | Recruiting | Novartis Pharmaceuti... | An International Prospective Open-l... |
| [NCT06659614](https://clinicaltrials.gov/study/NCT06659614) | N/A | Recruiting | Abramson Cancer Cent... | Prostate Tissue Biobank for People ... |
| [NCT06100705](https://clinicaltrials.gov/study/NCT06100705) | Phase 2 | Recruiting | Yale University | A Single Arm Open-label, Phase II S... |
| [NCT06136650](https://clinicaltrials.gov/study/NCT06136650) | Phase 3 | Recruiting | Merck Sharp & Dohme ... | MK-5684-004: A Phase 3, Randomized,... |
| [NCT05766371](https://clinicaltrials.gov/study/NCT05766371) | Phase 2 | Recruiting | University of Califo... | A Phase 2 Study of Pembrolizumab Pl... |
| [NCT04808427](https://clinicaltrials.gov/study/NCT04808427) | Not Applicable | Recruiting | National Cancer Inst... | Magnetic Resonance Image (MRI) Guid... |
| [NCT05743621](https://clinicaltrials.gov/study/NCT05743621) | Phase 1 | Recruiting | Weill Medical Colleg... | A Phase I, Open-Label, Dose-Finding... |

*... and 50 more trials (see trials.csv for full list)*
